Evidence map›Paper›PMID 18715757›Full record

SynthesisSchizophrenia research2008

Genetic associations with schizophrenia: meta-analyses of 12 candidate genes.

Jiajun Shi, Elliot S Gershon, Chunyu Liu

Abstract readMeta-Analysis
In one paragraph

Synthesis in Schizophrenia research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 6 pooled it
11.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 6 syntheses or guidelines pooled it, 161 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Genes · 2024
    Article
  9. Article
  10. Review
  11. Article
  12. The association of GABRB2 SNPs with cognitive function in schizophrenia.European archives of psychiatry and clinical neuroscience · 2020
    Article
  13. Review
  14. Article
  15. Article
  16. Highly Recurrent Copy Number Variations inFrontiers in psychiatry · 2020
    Article
  17. Article
  18. Double-Edged Sword of Tumour Suppressor Genes in Schizophrenia.Frontiers in molecular neuroscience · 2019
    Review
  19. Association between theNeuropsychiatric disease and treatment · 2019
    Article
  20. NMDAR Hypofunction Animal Models of Schizophrenia.Frontiers in molecular neuroscience · 2019
    Review

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jiajun ShiDepartment of Psychiatry, The University of Chicago, Chicago, IL 60637, USA. jjandshi@gmail.com
Elliot S Gershon
Chunyu Liu
University of Chicago · US

Funding

Fine Genomic Mapping of 13q32 in Bipolar DisorderR01MH065560 · NIMH · UNIVERSITY OF CHICAGO · PI GERSHON, ELLIOT S · 2002 to 2006
$3.0M
GENETIC LINKAGE STUDIES IN BIPOLAR DISORDERSR01MH061613 · NIMH · UNIVERSITY OF CHICAGO · PI GERSHON, ELLIOT S · 2000 to 2009
$2.8M
NIMH NIH HHS MH065560-02NIMH NIH HHS MH61613-05A1NIMH NIH HHS R01 MH061613NIMH NIH HHS R01 MH065560
6 · The paper itself

Abstract

Genetic association studies on schizophrenia (SZ) have been repeatedly performed over the last two decades, resulting in a consensus that results are generally inconsistent. This consensus has begun to change as a result of meta-analyses (e.g., [Glatt, S.J. and Jonsson, E.G., 2006. The Cys allele of the DRD2 Ser311Cys polymorphism has a dominant effect on risk for schizophrenia: evidence from fixed- and random-effects meta-analyses. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 141, 149-154.]). The SchizophreniaGene database (http://www.schizophreniaforum.org/res/sczgene/default.asp) has been a leader in meta-analyses of SZ association data, by dynamically and comprehensively cataloging all public genetic association studies, and preparing meta-analyses of case-control data. There are 19 "top" candidate genes from these analyses (access on December 20, 2007), showing the highest effect sizes and nominally significant associations of at least one variant in the meta-analyses of all ethnic samples or of samples of Caucasian ancestry. We selected 40 polymorphisms in 12 selected "top" genes for additional meta-analyses, which had at least one familial association data. We found gene-wide (correction for the number of meta-analyses for each gene) significant allelic association evidence for seven genes in the combined samples. The odds ratios (ORs) of the associated minor risk alleles range from 1.072 to 1.121, for DRD4, MTHFR, PPP3CC and TP53. For protective allele associations, the ORs are between 0.842 and 0.886, for DAO, IL1B, and SLC6A4. In population-based sub-analyses, we found significant results in four genes in Asians (ORs between 1.084 and 1.309 for DRD4, GABRB2, PPP3CC, and TP53), and one gene in European (OR of 0.888 for SLC6A4). The association of rs1816072 of GABRB2 with SZ in Asians was significant (adjusted P=0.048 after correction for 80 tests). No significant heterogeneity between case-control and family-based study designs was detected in 35 out of 40 polymorphisms. Our results further support eight potential SZ candidate genes and suggest that family data can reasonably be included in the meta-analysis of genetic associations.

Indexed as

AllelesGene ExpressionGene FrequencyHumansMinisatellite RepeatsPolymorphism, Single NucleotideRacial GroupsSchizophrenia

Identifiers

PMID18715757
PMCPMC2562556
OpenAlexW2121379565

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.